Headlines

Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone

Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone

Multiple myeloma uses a trick akin to a wolf in sheep's clothing to grow in and spread to new bone sites.

HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence

HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence

Patients with oropharyngeal cancer who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva.

Delayed referrals, diagnoses undermine cancer patients' faith in health care system

Delayed referrals, diagnoses undermine cancer patients' faith in health care system

Timeliness of referral for cancer tests can have a significant impact on patients' overall satisfaction.

Alcohol Consumption Linked with Less Disability in Chronic Pain

Alcohol Consumption Linked with Less Disability in Chronic Pain

Moderate to heavy drinking might cut the likelihood of disability for people with chronic widespread pain.

MRI, near-infrared spectral tomography combination increases specificity in breast cancer imaging

MRI, near-infrared spectral tomography combination increases specificity in breast cancer imaging

Magnetic resonance imaging (MRI) and near-infrared spectral tomography (NIRST) is feasible and more accurate than MRI alone

Teen exercise may reduce risk of dying from cancer during adulthood in women

Teen exercise may reduce risk of dying from cancer during adulthood in women

Exercise women performed during their teenage years may have an impact on their risk of dying from cancer or other causes as adults.

Researchers identify lynchpin molecule for prostate cancer metastasis

Researchers identify lynchpin molecule for prostate cancer metastasis

A single molecule appears to be the central regulator driving metastasis in prostate cancer.

Online registry improves clinical research study participation

Online registry improves clinical research study participation

An online registry that matches women with research studies and clinical trials enrolled study participants more quickly.

Five-day aprepitant versus fosaprepitant in patients receiving cisplatin

Five-day aprepitant versus fosaprepitant in patients receiving cisplatin

Single administration of fosaprepitant meglumine no less effective for preventing acute and delayed nausea and vomiting symptoms.

Black men twice as likely to die from prostate cancer compared to white men

Black men twice as likely to die from prostate cancer compared to white men

Black men are twice as likely to be diagnosed with, or die from, prostate cancer in their lifetime compared to white men.

Conference Coverage

Managing oral oncology/hematology treatments in your practice

An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.

Follow-up PET/CT more than 95% sensitive for non-Hodgkin lymphoma

BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.

Distinct triple-positive subtypes identified in breast cancer

CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.

Removing more breast tissue reduces the need for a second cancer surgery

Expanded surgical margins during a partial mastectomy could be beneficial for patients, preventing further surgery.

Next-generation ALK-inhibitor brigatinib promising against NSCLC

Clinical trial results showed good performance employing the investigational drug brigatinib against ALK-positive non-small cell lung cancer (NSCLC).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs